Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Leiden Bio Science Park (LBSP) had the honor of hosting a Swiss delegation, organized by Roche, Novartis, Rijksdienst voor Ondernemend Nederland, Health Holland, and other partners. The visit showcased the innovative collaborations and research driving advancements in health and life sciences.
The program included several highlights:
The delegation visited fundamental LBSP locations, including:
They introduced presentations from:
These presentations highlighted the diverse health-focused initiatives thriving at LBSP.
The day concluded with a presentation by Thomas Hankemeier on the ExposomeScan, a revolutionary tool connecting environmental factors to medical insights, paving the way for improved health research.
As of June, the Leiden Bio Science Park team has been joined by Gerwin Zomer, who steps into the role of Account Manager Physical Living Environment. To get to know him a bit...
Researchers at the Leiden University Medical Center (LUMC) have announced promising early results from a clinical trial using lab-grown insulin-producing islet cells derived from...
VarmX has received IND approval for its Phase 3 trial of VMX‑C001, a recombinant factor X variant designed to neutralize FXa‑inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a €15 million EIC investment, this step positions VMX‑C001 to meet a gap in urgent haemostasis care.